Literature DB >> 25613380

eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.

M Stoneley1, A E Willis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25613380      PMCID： PMC4356343          DOI： 10.1038/cdd.2014.210

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  14 in total

Review 1.  Dysregulation of protein synthesis and disease.

Authors:  John P C Le Quesne; Keith A Spriggs; Martin Bushell; Anne E Willis
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 2.  The biological and therapeutic relevance of mRNA translation in cancer.

Authors:  Sarah P Blagden; Anne E Willis
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

3.  Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity.

Authors:  Kateryna Feoktistova; Enkhee Tuvshintogs; Angelie Do; Christopher S Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

Review 4.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

5.  Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.

Authors:  Marie-Eve Bordeleau; Ayaka Mori; Monika Oberer; Lisa Lindqvist; Louisa S Chard; Tatsuo Higa; Graham J Belsham; Gerhard Wagner; Junichi Tanaka; Jerry Pelletier
Journal:  Nat Chem Biol       Date:  2006-03-12       Impact factor: 15.040

6.  The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.

Authors:  David M Lucas; Ryan B Edwards; Gerard Lozanski; Derek A West; Jungook D Shin; Melissa A Vargo; Melanie E Davis; Darlene M Rozewski; Amy J Johnson; Bao-Ning Su; Virginia M Goettl; Nyla A Heerema; Thomas S Lin; Amy Lehman; Xiaoli Zhang; David Jarjoura; David J Newman; John C Byrd; A Douglas Kinghorn; Michael R Grever
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

7.  The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.

Authors:  A Modelska; E Turro; R Russell; J Beaton; T Sbarrato; K Spriggs; J Miller; S Gräf; E Provenzano; F Blows; P Pharoah; C Caldas; J Le Quesne
Journal:  Cell Death Dis       Date:  2015-01-22       Impact factor: 8.469

8.  Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.

Authors:  Regina Cencic; Marilyn Carrier; Gabriela Galicia-Vázquez; Marie-Eve Bordeleau; Rami Sukarieh; Annie Bourdeau; Brigitte Brem; Jose G Teodoro; Harald Greger; Michel L Tremblay; John A Porco; Jerry Pelletier
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

9.  Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.

Authors:  R Cencic; F Robert; G Galicia-Vázquez; A Malina; K Ravindar; R Somaiah; P Pierre; J Tanaka; P Deslongchamps; J Pelletier
Journal:  Blood Cancer J       Date:  2013-07-19       Impact factor: 11.037

10.  A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Authors:  E Horvilleur; T Sbarrato; K Hill; R V Spriggs; M Screen; P J Goodrem; K Sawicka; L C Chaplin; C Touriol; G Packham; K N Potter; S Dirnhofer; A Tzankov; M J S Dyer; M Bushell; M MacFarlane; A E Willis
Journal:  Leukemia       Date:  2013-10-18       Impact factor: 11.528
View more
  5 in total

Review 1.  Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.

Authors:  Ashwin Sriram; Jonathan Bohlen; Aurelio A Teleman
Journal:  EMBO Rep       Date:  2018-09-17       Impact factor: 8.807

2.  Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.

Authors:  Mengxiang Zhao; Liang Ding; Yan Yang; Sheng Chen; Nisha Zhu; Yong Fu; Yanhong Ni; Zhiyong Wang
Journal:  Cancer Manag Res       Date:  2019-11-11       Impact factor: 3.989

3.  Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.

Authors:  Forum Kayastha; Noah B Herrington; Bandish Kapadia; Anirban Roychowdhury; Nahid Nanaji; Glen E Kellogg; Ronald B Gartenhaus
Journal:  Mol Med       Date:  2022-09-04       Impact factor: 6.376

4.  eIF4A RNA Helicase Associates with Cyclin-Dependent Protein Kinase A in Proliferating Cells and Is Modulated by Phosphorylation.

Authors:  Maxwell S Bush; Olivier Pierrat; Candida Nibau; Veronika Mikitova; Tao Zheng; Fiona M K Corke; Konstantinos Vlachonasios; Laura K Mayberry; Karen S Browning; John H Doonan
Journal:  Plant Physiol       Date:  2016-07-07       Impact factor: 8.340

5.  The RNA helicase, eIF4A-1, is required for ovule development and cell size homeostasis in Arabidopsis.

Authors:  Maxwell S Bush; Natalie Crowe; Tao Zheng; John H Doonan
Journal:  Plant J       Date:  2015-12       Impact factor: 6.417
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.